Asian Penny Stocks Under US$10B Market Cap: 3 Picks To Consider

Amidst global market volatility driven by geopolitical tensions and fluctuating energy prices, Asian markets have been navigating a complex landscape. This environment has prompted investors to look beyond traditional large-cap stocks, turning their attention to opportunities in smaller or newer companies often categorized as penny stocks. Though the term 'penny stock' may seem outdated, it remains relevant for those seeking potential growth in companies with solid financial foundations. Here, we explore three such stocks that combine balance sheet strength with promising prospects for long-term gains.

Top 10 Penny Stocks In Asia

Name	Share Price	Market Cap	Rewards & Risks
North East Rubber (SET:NER)	THB4.86	THB8.98B	✅ 5 ⚠️ 2 View Analysis >
Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)	THB3.44	THB1.43B	✅ 3 ⚠️ 3 View Analysis >
YesAsia Holdings (SEHK:2209)	HK$3.13	HK$1.31B	✅ 4 ⚠️ 3 View Analysis >
PC Partner Group (SGX:PCT)	SGD1.35	SGD523.64M	✅ 4 ⚠️ 2 View Analysis >
CNMC Goldmine Holdings (Catalist:5TP)	SGD1.51	SGD611.99M	✅ 4 ⚠️ 2 View Analysis >
Atlantic Navigation Holdings (Singapore) (Catalist:5UL)	SGD0.117	SGD61.25M	✅ 1 ⚠️ 5 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)	SGD3.96	SGD15.58B	✅ 4 ⚠️ 2 View Analysis >
TeleChoice International (SGX:T41)	SGD0.195	SGD88.6M	✅ 4 ⚠️ 2 View Analysis >
Bosideng International Holdings (SEHK:3998)	HK$4.07	HK$47.3B	✅ 4 ⚠️ 2 View Analysis >
Scott Technology (NZSE:SCT)	NZ$2.37	NZ$200.99M	✅ 4 ⚠️ 0 View Analysis >

Click here to see the full list of 922 stocks from our Asian Penny Stocks screener.

We'll examine a selection from our screener results.

SenseTime Group (SEHK:20)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: SenseTime Group Inc. is an investment holding company that researches, develops, and sells artificial intelligence software platforms across Mainland China, Northeast Asia, Southeast Asia, and internationally with a market cap of HK$76.40 billion.

Operations: The company's revenue primarily comes from its Software & Programming segment, which generated CN¥5.01 billion.

Market Cap: HK$76.4B

SenseTime Group has demonstrated financial improvement with revenue of CN¥5.01 billion for 2025, up from the previous year, while significantly reducing its net loss to CN¥1.77 billion. Despite being unprofitable with a negative return on equity, the company has a stable cash runway exceeding three years and more cash than debt, indicating solid liquidity management. The management and board are experienced, contributing to strategic stability as they navigate growth opportunities in AI software platforms across Asia. Shareholders have not faced significant dilution recently, and earnings are forecasted to grow substantially annually.

• Get an in-depth perspective on SenseTime Group's performance by reading our balance sheet health report here.
• Gain insights into SenseTime Group's outlook and expected performance with our report on the company's earnings estimates.

Sihuan Pharmaceutical Holdings Group (SEHK:460)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company involved in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in China and the United States, with a market cap of HK$13.17 billion.

Operations: Revenue Segments: No specific revenue segments have been reported for Sihuan Pharmaceutical Holdings Group Ltd.

Market Cap: HK$13.17B

Sihuan Pharmaceutical Holdings Group has recently turned profitable, reporting a net income of CN¥179.7 million for 2025, up from a loss the previous year. The company's strategic partnership with Biocytogen Pharmaceuticals aims to enhance its drug development capabilities, focusing on innovative therapies. Sihuan's financial position is robust, with more cash than debt and short-term assets exceeding liabilities. Its medical aesthetics business now leads revenue generation, contributing significantly to improved profitability. While earnings have been volatile historically, they are forecasted to grow substantially. The management and board are experienced, supporting the company's strategic direction in pharmaceuticals and medical aesthetics.

• Navigate through the intricacies of Sihuan Pharmaceutical Holdings Group with our comprehensive balance sheet health report here.
• Explore Sihuan Pharmaceutical Holdings Group's analyst forecasts in our growth report.

Yangzijiang Shipbuilding (Holdings) (SGX:BS6)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Yangzijiang Shipbuilding (Holdings) Ltd. is an investment holding company involved in shipbuilding activities across Greater China and various international markets, with a market cap of SGD15.58 billion.

Operations: The company generates revenue primarily from its shipbuilding segment, which accounts for CN¥26.83 billion, followed by the shipping segment at CN¥1.14 billion.

Market Cap: SGD15.58B

Yangzijiang Shipbuilding (Holdings) Ltd. demonstrates strong financial health with short-term assets of CN¥43.3 billion surpassing both its long-term liabilities and short-term obligations, indicating robust liquidity. The company's earnings for 2025 reached CN¥8.64 billion, reflecting significant growth from the previous year and showcasing a high net profit margin of 30.3%. Despite legal challenges, recent arbitration awards have been upheld in Yangzijiang's favor, providing some stability amid uncertainties. However, while the company trades at a substantial discount to its estimated fair value, its dividend is not well covered by free cash flows, suggesting potential sustainability concerns.

• Click here to discover the nuances of Yangzijiang Shipbuilding (Holdings) with our detailed analytical financial health report.
• Assess Yangzijiang Shipbuilding (Holdings)'s future earnings estimates with our detailed growth reports.

Summing It All Up

• Unlock more gems! Our Asian Penny Stocks screener has unearthed 919 more companies for you to explore.Click here to unveil our expertly curated list of 922 Asian Penny Stocks.
• Want To Explore Some Alternatives? This technology could replace computers: discover the 25 stocks are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com